13F HOLDINGS REPORT
DAFNA Capital Management LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001389933-23-000008
Total Value
$365.7M
Positions
73
Other Managers
1
Confidential Omitted
No
Holdings (73)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P BIOTECH ETF | 78464A870 | 565,000 | $47.0M | 12.85% |
| 2 | IVERIC BIO INC | 46583P102 | 612,975 | $24.1M | 6.59% |
| 3 | STEREOTAXIS INC | STXS | 13,680,554 | $20.9M | 5.72% |
| 4 | BLUEPRINT MEDICINES CORP | 09627Y109 | 251,521 | $15.9M | 4.35% |
| 5 | REVOLUTION MEDICINES INC | RVMDW | 512,285 | $13.7M | 3.75% |
| 6 | ISHARES NASDAQ BIOTECH INDX | 464287556 | 102,500 | $13.0M | 3.56% |
| 7 | ASCENDIS PHARMA A/S | ASND | 135,212 | $12.1M | 3.30% |
| 8 | MORPHIC HOLDING INC | 61775R105 | 206,748 | $11.9M | 3.24% |
| 9 | IDEAYA BIOSCIENCES INC | IDYA | 479,820 | $11.3M | 3.08% |
| 10 | CYTOKINETICS INC | CYTK | 332,734 | $10.9M | 2.97% |
| 11 | XENON PHARMACEUTICALS INC | XENE | 280,538 | $10.8M | 2.95% |
| 12 | MERUS N V | N5749R100 | 384,870 | $10.1M | 2.77% |
| 13 | SYNDAX PHARMACEUTICALS INC | SNDX | 450,873 | $9.4M | 2.58% |
| 14 | KARUNA THERAPEUTICS INC | 48576A100 | 42,173 | $9.1M | 2.50% |
| 15 | DEXCOM INC | DXCM | 67,552 | $8.7M | 2.37% |
| 16 | SAGE THERAPEUTICS INC | 78667J108 | 180,306 | $8.5M | 2.32% |
| 17 | NEUROCRINE BIOSCIENCES INC | NBIX | 74,615 | $7.0M | 1.92% |
| 18 | ATRICURE INC | ATRC | 125,529 | $6.2M | 1.69% |
| 19 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 507,100 | $6.1M | 1.66% |
| 20 | DICE THERAPEUTICS INC | 23345J104 | 127,585 | $5.9M | 1.62% |
| 21 | NURIX THERAPEUTICS INC | NRIX | 556,695 | $5.6M | 1.52% |
| 22 | KALVISTA PHARMACEUTICALS INC | KALV | 611,032 | $5.5M | 1.50% |
| 23 | 2SEVENTY BIO INC | 901384107 | 496,416 | $5.0M | 1.37% |
| 24 | VIKING THERAPEUTICS INC | VKTX | 293,655 | $4.8M | 1.30% |
| 25 | ACCURAY INC | ARAY | 1,222,358 | $4.7M | 1.29% |
| 26 | ARCUS BIOSCIENCES INC | RCUS | 225,717 | $4.6M | 1.25% |
| 27 | CENTURY THERAPEUTICS INC | IPSC | 1,307,407 | $4.1M | 1.13% |
| 28 | EDGEWISE THERAPEUTICS INC | EWTX | 519,384 | $4.0M | 1.10% |
| 29 | BIOCRYST PHARMACEUTICALS INC | BCRX | 569,000 | $4.0M | 1.10% |
| 30 | ALECTOR INC | ALEC | 638,938 | $3.8M | 1.05% |
| 31 | KURA ONCOLOGY INC | KURA | 357,784 | $3.8M | 1.04% |
| 32 | ASCENDIS PHARMA A/S | ASND | 4,000,000 | $3.6M | 0.99% |
| 33 | MIRATI THERAPEUTICS INC | 60468T105 | 94,700 | $3.4M | 0.94% |
| 34 | BICYCLE THERAPEUTICS PLC | BCYC | 122,200 | $3.1M | 0.85% |
| 35 | AXOGEN INC | AXGN | 332,103 | $3.0M | 0.83% |
| 36 | MEDIWOUND LTD | MDWD | 257,653 | $2.7M | 0.75% |
| 37 | TANDEM DIABETES CARE INC | TNDM | 110,000 | $2.7M | 0.74% |
| 38 | MERSANA THERAPEUTICS INC | 59045L106 | 810,845 | $2.7M | 0.73% |
| 39 | AUTOLUS THERAPEUTICS PLC | AUTL | 930,394 | $2.2M | 0.61% |
| 40 | GALAPAGOS NV | GLPGF | 52,675 | $2.1M | 0.59% |
| 41 | ADICET BIO INC | ACET | 797,054 | $1.9M | 0.53% |
| 42 | KEROS THERAPEUTICS INC | KROS | 47,661 | $1.9M | 0.52% |
| 43 | REGULUS THERAPEUTICS INC | 75915K309 | 1,111,049 | $1.6M | 0.45% |
| 44 | VIGIL NEUROSCIENCE INC | 92673K108 | 172,308 | $1.6M | 0.44% |
| 45 | PROQR THERAPEUTICS N V | N71542109 | 940,582 | $1.5M | 0.42% |
| 46 | LYRA THERAPEUTICS INC | LYRA | 361,084 | $1.5M | 0.41% |
| 47 | MEREO BIOPHARMA GROUP PLC | MREO | 1,009,013 | $1.3M | 0.36% |
| 48 | ITEOS THERAPEUTICS INC | 46565G104 | 98,560 | $1.3M | 0.36% |
| 49 | BRAINSWAY LTD | BRSYF | 504,681 | $1.2M | 0.31% |
| 50 | SUTRO BIOPHARMA INC | STRO | 242,779 | $1.1M | 0.31% |
| 51 | LARIMAR THERAPEUTICS INC | LRMR | 350,373 | $1.1M | 0.30% |
| 52 | ASTRIA THERAPEUTICS INC | 04635X102 | 127,653 | $1.1M | 0.29% |
| 53 | ACRIVON THERAPEUTICS INC | ACRV | 76,852 | $996,002 | 0.27% |
| 54 | SURFACE ONCOLOGY INC | 86877M209 | 1,100,000 | $956,560 | 0.26% |
| 55 | SYROS PHARMACEUTICALS INC | 87184Q206 | 265,878 | $837,516 | 0.23% |
| 56 | PARDES BIOSCIENCES INC | 69945Q105 | 430,291 | $778,827 | 0.21% |
| 57 | NEVRO CORP | 64157F103 | 28,000 | $711,760 | 0.19% |
| 58 | ELEVATION ONCOLOGY INC | 28623U101 | 450,000 | $684,000 | 0.19% |
| 59 | NEURONETICS INC | STIM | 313,717 | $674,492 | 0.18% |
| 60 | SPRUCE BIOSCIENCES INC | SPRB | 312,000 | $670,800 | 0.18% |
| 61 | BIOHAVEN LTD | BHVN | 21,113 | $505,023 | 0.14% |
| 62 | MASIMO CORP | MASI | 3,000 | $493,650 | 0.13% |
| 63 | COMPASS THERAPEUTICS INC | CMPX | 116,882 | $371,685 | 0.10% |
| 64 | KARYOPHARM THERAPEUTICS INC | KPTI | 192,678 | $344,894 | 0.09% |
| 65 | NEXTCURE INC | NXTC | 187,696 | $337,853 | 0.09% |
| 66 | ADAPTIMMUNE THERAPEUTICS PLC | ADTI | 351,064 | $324,734 | 0.09% |
| 67 | MEDICENNA THERAPEUTICS CORP | MDNAF | 660,000 | $317,922 | 0.09% |
| 68 | PROCEPT BIOROBOTICS CORP | PRCT | 8,000 | $282,800 | 0.08% |
| 69 | KINNATE BIOPHARMA INC | 49705R105 | 80,179 | $242,942 | 0.07% |
| 70 | COMPUGEN LTD | CGEN | 205,202 | $233,930 | 0.06% |
| 71 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 140,000 | $197,400 | 0.05% |
| 72 | SPERO THERAPEUTICS INC | SPRO | 125,000 | $181,250 | 0.05% |
| 73 | INOGEN INC | INGN | 15,000 | $173,250 | 0.05% |